RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 2.79 TRY -2.45% Market Closed
Market Cap: 1.4B TRY

Gross Margin
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

28.8%
Current
27%
Average
63%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
28.8%
=
Gross Profit
60.8m
/
Revenue
210.8m

Gross Margin Across Competitors

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Glance View

Market Cap
1.4B TRY
Industry
Biotechnology

RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

RTALB.E Intrinsic Value
1.94 TRY
Overvaluation 31%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
28.8%
=
Gross Profit
60.8m
/
Revenue
210.8m
What is the Gross Margin of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS?

Based on RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's most recent financial statements, the company has Gross Margin of 28.8%.

Back to Top